Multi-Zyme
Multi-Zyme, licence 80075925: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Canada Greenfield Natural Health Products Co. Ltd.
- NPN or DIN-HM
- 80075925
- Status
- Active licence
- Licence date
- 3 March 2017
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Protéase Source : Protéase fongique | 1260.0 Unités d'hémoglobine basées sur la tyrosine, du FCC | Not calculated |
| Protéase Source : Protéase fongique | 70.0 mg | Not calculated |
| Diastase du malt Source : Diastase du malt | 270.0 Unités de degrés de pouvoir diastatique du FCC | Not calculated |
| bêta-D-galactoside galactohydrolase Source : Lactase | 117.0 FCC ALU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Cellulase | 20.0 mg | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Cellulase | 70.0 FCC CU | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Alpha-amylase | 140.0 mg | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Alpha-amylase | 3080.0 Unités d'alpha-amylase dextrinifiante du FCC | Not calculated |
| Diastase du malt Source : Diastase du malt | 60.0 mg | Not calculated |
| Triacylglycérol lipase Source : Triacylglycerol lipase | 80.0 mg | Not calculated |
| Triacylglycérol lipase Source : Triacylglycerol lipase | 96.0 FCC LU | Not calculated |
| bêta-D-galactoside galactohydrolase Source : Lactase | 30.0 mg | Not calculated |
| bêta-fructofuranosidase Source : Invertase | 30.0 mg | Not calculated |
| bêta-fructofuranosidase Source : Invertase | 129.0 FCC INVU | Not calculated |
Non-medicinal ingredients
Poudre d'Oryza Sativa (Riz), Stéarate de magnésium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1.0 Capsule ; maximum: 2.0 Capsule | minimum: 1.0 Tous les jours ; maximum: 3.0 Tous les jours |
Uses authorised in Canada
(1) Digestive enzymes. (2) Digestive aid. (3) Help digest proteins.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity/allergy has been known to occur; in such a case, discontinue use.
- Précautions et mises en garde
(1) If you are pregnant or breastfeeding, consult a health care practitioner prior to use. (2) If you have diabetes, consult a health care practitioner prior to use. (3) If you have gastrointestinal lesions/ulcers, are taking anticoagulant agents or anti-inflammatory agents, or are having surgery, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80075925
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.